Clinical Evaluation Study of a Device for Detecting Arteriovenous Fistula Vascular Function

Launched by AI PENG · Sep 4, 2022

Keywords

ClinConnect Summary

This clinical trial is studying a new wearable device designed to monitor the function of arteriovenous fistulas, which are important for patients undergoing dialysis for kidney failure. The device uses a unique technology based on voiceprints to help detect any problems early, ensuring better care for those with end-stage renal failure. The trial is currently recruiting participants aged 18 to 75 who are scheduled for fistula surgery or are receiving hemodialysis.

Participants in the trial will wear the device and help researchers evaluate its reliability, safety, and practicality. It’s important to note that pregnant women and individuals with certain mental health conditions are not eligible to participate. Those who join the study will be contributing to the development of a tool that could improve the management of vascular health in patients needing dialysis.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age 18-75.
• • Patients diagnosed with end-stage renal failure and planning to undergo venous fistula surgery or maintenance hemodialysis.
• • Sign the informed consent.
• Exclusion Criteria:
• • Pregnant and lactating women, bipolar disorder, schizophrenia and other serious mental illness.
• • Other circumstances deemed inappropriate by the researcher
• • Quit midway